MCP-3 Activators
The chemical class of MCP-3 activators includes a variety of compounds primarily known for their roles in modulating inflammation and immune responses. These activators, mainly consisting of nonsteroidal anti-inflammatory drugs (NSAIDs), glucocorticoids, and other anti-inflammatory agents, highlight the complex interaction between inflammatory pathways and the regulation of chemokines like MCP-3. NSAIDs such as aspirin, ibuprofen, indomethacin, naproxen, and celecoxib play a significant role in this class. Their mechanism of action involves the inhibition of cyclooxygenase enzymes, leading to a reduction in prostaglandin synthesis. This modulation of the inflammatory cascade can indirectly influence MCP-3 expression, reflecting the chemokine's role in recruiting immune cells and mediating inflammatory responses. The impact of these drugs on MCP-3 expression underscores the broader effects of anti-inflammatory therapies on immune signaling and chemokine regulation.
Glucocorticoids, including prednisolone, hydrocortisone, and dexamethasone, represent another important aspect of this class. Their potent anti-inflammatory and immunosuppressive effects are mediated through glucocorticoid receptors, leading to modulation of gene expression related to inflammation and immune responses. These agents' ability to influence MCP-3 expression through their action on inflammatory pathways demonstrates the intricate balance of immune regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
As an NSAID, aspirin can modulate inflammatory pathways, potentially affecting MCP-3 expression through cyclooxygenase inhibition and prostaglandin synthesis reduction. | ||||||
Ibuprofen | 15687-27-1 | sc-200534 sc-200534A | 1 g 5 g | $53.00 $88.00 | 6 | |
Similar to aspirin, ibuprofen can modulate MCP-3 expression indirectly through its anti-inflammatory effects on cyclooxygenase and prostaglandin pathways. | ||||||
Prednisolone | 50-24-8 | sc-205815 sc-205815A | 1 g 5 g | $84.00 $253.00 | 2 | |
A glucocorticoid that influences inflammatory responses, potentially affecting MCP-3 expression through glucocorticoid receptor-mediated pathways. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Used in autoimmune diseases, methotrexate can modulate immune responses, potentially affecting MCP-3 expression through its anti-inflammatory and immunosuppressive effects. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
A corticosteroid that modulates inflammation, potentially influencing MCP-3 expression through glucocorticoid receptor-mediated anti-inflammatory pathways. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Used in gout treatment, colchicine can modulate inflammatory responses, potentially affecting MCP-3 expression through inhibition of microtubule polymerization and leukocyte activity. | ||||||
Acetaminophen | 103-90-2 | sc-203425 sc-203425A sc-203425B | 25 g 100 g 500 g | $41.00 $61.00 $194.00 | 11 | |
While primarily an analgesic, acetaminophen can have mild anti-inflammatory effects, potentially influencing MCP-3 expression indirectly. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $29.00 $38.00 | 18 | |
A potent NSAID, indomethacin can modulate MCP-3 expression through its effects on cyclooxygenase and subsequent prostaglandin synthesis. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Another glucocorticoid, dexamethasone can influence MCP-3 expression through its potent anti-inflammatory and immunosuppressive effects. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Used in inflammatory bowel disease, sulfasalazine can indirectly affect MCP-3 expression through its anti-inflammatory properties. | ||||||